1. Home
  2. NKTR vs PBPB Comparison

NKTR vs PBPB Comparison

Compare NKTR & PBPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • PBPB
  • Stock Information
  • Founded
  • NKTR 1990
  • PBPB 1977
  • Country
  • NKTR United States
  • PBPB United States
  • Employees
  • NKTR N/A
  • PBPB N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • PBPB Restaurants
  • Sector
  • NKTR Health Care
  • PBPB Consumer Discretionary
  • Exchange
  • NKTR Nasdaq
  • PBPB Nasdaq
  • Market Cap
  • NKTR 238.7M
  • PBPB 232.8M
  • IPO Year
  • NKTR 1994
  • PBPB 2013
  • Fundamental
  • Price
  • NKTR $1.35
  • PBPB $8.28
  • Analyst Decision
  • NKTR Buy
  • PBPB Strong Buy
  • Analyst Count
  • NKTR 4
  • PBPB 3
  • Target Price
  • NKTR $2.50
  • PBPB $15.67
  • AVG Volume (30 Days)
  • NKTR 982.8K
  • PBPB 171.2K
  • Earning Date
  • NKTR 11-05-2024
  • PBPB 10-30-2024
  • Dividend Yield
  • NKTR N/A
  • PBPB N/A
  • EPS Growth
  • NKTR N/A
  • PBPB 178.24
  • EPS
  • NKTR N/A
  • PBPB 1.19
  • Revenue
  • NKTR $93,157,000.00
  • PBPB $477,366,000.00
  • Revenue This Year
  • NKTR N/A
  • PBPB N/A
  • Revenue Next Year
  • NKTR N/A
  • PBPB $3.41
  • P/E Ratio
  • NKTR N/A
  • PBPB $6.77
  • Revenue Growth
  • NKTR 6.17
  • PBPB N/A
  • 52 Week Low
  • NKTR $0.41
  • PBPB $6.28
  • 52 Week High
  • NKTR $1.93
  • PBPB $14.36
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 58.23
  • PBPB 54.31
  • Support Level
  • NKTR $1.11
  • PBPB $7.98
  • Resistance Level
  • NKTR $1.39
  • PBPB $8.54
  • Average True Range (ATR)
  • NKTR 0.09
  • PBPB 0.23
  • MACD
  • NKTR 0.01
  • PBPB -0.01
  • Stochastic Oscillator
  • NKTR 85.71
  • PBPB 46.48

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About PBPB Potbelly Corporation

Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.

Share on Social Networks: